Home > Insider Trading > Filing (0001562180-17-003064)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1100412	Array Biopharma Inc	ARRY	Pharmaceutical Preparations (2834)	841460811

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1191818	Kyle Lefkoff	C/O Boulder Ventures 1941 Pearl Street, Suite 300 Boulder CO 80302		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-09-29	45,000	$10.58	51,585	No	4	M	Direct
Common Stock	Disposition	2017-09-29	38,865	$12.31	12,720	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2017-09-29	45,000	$0.00	45,000	$10.58

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2010-11-01	2017-11-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	45,000	Indirect	See footnote

Footnotes

This Form 4 is reporting the exercise by the reporting person of an option scheduled to expire on November 1, 2017 and the sale of a portion of the option shares to satisfy payment of the option exercise price.
Comprised of 30,000 shares of common stock in trust for the benefit of Mr. Lefkoff's minor children and 15,000 shares of common stock held by BV Partners III Profit Sharing account for the benefit of Mr. Lefkoff.
The option vested in 3 equal annual installments beginning on November 1, 2008.